Meredith Wilson

Bio:

Meredith is a strategic powerhouse with over 25 years of experience leading advocacy, patient engagement, education, and health equity initiatives across clinical and commercial teams.

Leveraging extensive experience in advocacy, patient engagement, and healthcare communications, Meredith launched the Advocacy & Patient Affairs (APA) Team at Syneos Health in early 2022. Under her leadership, APA collaborates closely with pharmaceutical and biotech clients to develop and implement patient engagement and advocacy strategies. The APA team specializes in creating innovative, patient-partnered approaches that ensure patient needs, burdens, and preferences shape the development and delivery of transformative therapies. This unique model delivers flexible, meaningful solutions that keep patient communities at the forefront, driving impactful change and improved outcomes.

Meredith Co-Leads the Syneos Health Rare Disease Consortium and established the Patient Powered Medicine Center of Excellence in 2024, bringing together experts from across the company to create solutions to support patient collaboration in clinical development and commercialization. 

Meredith's expertise covers numerous therapeutic areas, including rare disease, gene therapy, neurology, and oncology. She has successfully led large teams responsible for strategic account service, brand development, content strategy, and execution, consistently aligning objectives to support growth and enhance patient care.

Previously, as the founder of the Healthcare Partnerships Strategy and Education Departments at the Muscular Dystrophy Association (MDA), Meredith developed innovative partnership methodologies and educational platforms to support individuals and families impacted by neuromuscular disorders.

Meredith holds a double degree in international relations and Russian language from the University of Wisconsin-Madison, with additional studies at Moscow State University.